5th European Phenylketonuria Group (EPG) Symposium “Advances and Challenges in PKU
Phenylketonuria (PKU) is an active field of investigation, and new diagnostic and treatment options are emerging that may
reduce the burden of a life-long and limiting dietary management for these patients, their families and the society.
Basic and clinical research is today focusing on brain metabolism in PKU patients and its repercussion on neurological functions,
on a better clinical characterization by biochemical and genetic analysis, and also on developing new therapeutic strategies
or implementing the use of those already available, such as diet and sapropterin dihydrochloride,
Furthermore, evidence-based international guidelines are being developed to provide standardization in PKU management, including
appropriate biomolecular diagnosis, treatment’s choice, evaluation of response to therapy, and achievement of targeted blood
phenylalanine levels, also considering the social and economical impact of this disease.
The European Phenylketonuria Group (EPG) together with Serono Symposia International Foundation (SSIF) consider essential
to continue their series of successful meetings on PKU, and are organizing the 2013 annual symposium dedicated to that. Aims
of this meeting are to review the most important achievements of research in the field of PKU and to provide participants
with solutions for optimizing patient management in their daily clinical practice.
After attending the symposium, participants will better understand the importance of and will be able to improve their clinical practice on the following aspects of PKU:
Specialists in pediatric and adult inherited metabolic disorders, dietitians, nutritionists, clinical biochemists and genetists, basic scientists, psychologists, nurses and all health care professionals dealing with PKU.
Serono Symposia International Foundation is conducting a Learning Effectiveness Project at meetings during 2013. The meeting ' 5th European Phenylketonuria Group Symposium 'Advances and Challenges in PKU' has been chosen to participate in this project.
Find out more about the Learning Effectiveness Project
Serono Symposia International Foundation (www.seronosymposia.org) is accredited by the European Accreditation Council for Continuing Medical Education (EACCME ® ) to provide the following CME activity for medical specialists. The EACCME ® is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
The conference 5 th European Phenylketonuria Group (EPG) Symposium “Advances and Challenges in PKU” (15-16 March 2013 -Istanbul, Turkey) is designated for a maximum of 9 (nine) hours of European CME credits (ECMEC). Each medical specialist should claim only those credits that he/she actually spent in the educational activity. EACCME ® credits are recognized by the American
Medical Association (AMA) towards the Physician's Recognition Award (PRA). To convert EACCME ® credit to AMA PRA category 1 credit, please contact the AMA.